Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
MedAlliance announces successful completion of enrolment in ISABELLA clinical trial for the treatment of failing AV fistulas in hemodialysis patients 2020-11-25 08:00
RedHill Biopharma to Present at Evercore ISI HealthCONx and Piper Sandler Healthcare Conferences 2020-11-25 07:00
Almirall announces collaborations with the University of South Australia and Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau 2020-11-25 06:00
China Biologic Reports Financial Results for the Third Quarter of 2020 2020-11-25 05:30
The cost of one dose of the Sputnik V vaccine will be less than $10 for international markets 2020-11-25 04:38
Second interim analysis of clinical trial data showed a 91.4% efficacy for the Sputnik V vaccine on day 28 after the first dose; vaccine efficacy is over 95% 42 days after the first dose 2020-11-24 22:14
OliPass Announces Formation of Scientific Advisory Board of Pioneers in Sodium Ion Channellopathy and Pain 2020-11-24 22:00
New Centre for Medicines Research (CMR) Clinical Factbook From Clarivate Highlights Increasing Cost and Complexity of Phase II Trials 2020-11-24 16:05
Koru Lifescience preparing to send drug compounds to preclinical and clinical trials based on their study for Covid-19 2020-11-24 04:35
3SBio Inc. received milestone payment of USD 4 million upon commencement of phase III clinical program of SEL-212 2020-11-23 21:28
Tony Blair Institute and Oracle Launch Africa Vaccine Management in the Cloud 2020-11-23 21:05
GemVax & KAEL reports further positive data from GV1001 Phase II Alzheimer's Disease trial 2020-11-23 20:00
Fresenius Kabi and ASPEN partner for an expert interview series on omega-3 fatty acid containing parenteral nutrition 2020-11-23 19:00
Innovent Announces NMPA Granted New Indication Approval for SULINNO® (Adalimumab Injection) in China for the Treatment of Polyarticular Juvenile Idiopathic Arthritis 2020-11-23 18:34
Ascentage Pharma Receives Approvals for Two Phase Ib/II Clinical Studies of the Bcl-2 Inhibitor APG-2575 for the Treatment of Waldenström Macroglobulinemia and Multiple Myeloma in China 2020-11-23 18:32
ESMO ASIA Congress 2020 | CStone Pharmaceuticals announces the results of GEMSTONE-302, Sugemalimab has the potential to provide a new treatment option for patients with advanced NSCLC 2020-11-23 09:30
Creation of a research partnership between Pierre Fabre and Y-Biologics for the development of new immunotherapies based on monoclonal antibodies 2020-11-23 09:00
Innovent Releases Phase 3 Results of TYVYT® (Sintilimab Injection) in Combination with BYVASDA® (Bevacizumab Biosimilar Injection) as First-Line Treatment in Patients with Advanced Hepatocellular Carcinoma (HCC) at ESMO ASIA Virtual Congress 2020 2020-11-23 08:00
Novel Antioxidant Seen as an Effective Strategy for Peripheral Artery Disease 2020-11-20 23:07
Antengene Corporation, an Innovative Cancer Biotech Company, is Listed on the Main Board of the Hong Kong Stock Exchange 2020-11-20 21:09
1 270 271 272 273 274 412